|
Market Closed -
Börse Stuttgart
01:26:28 28/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 36.28 EUR | -0.44% |
|
+2.65% | +45.76% |
| 11/08 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 | |
| 07/08 | Gedeon Richter PLC Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceuticals - Women's Healthcare (WHC) | - | - | 26TCr | 29TCr | 33TCr | |||||
Gross Profit | - | - | 17TCr | 19TCr | 22TCr | |||||
Operating Income | - | - | 3.94TCr | 4.43TCr | 5.31TCr | |||||
Pharmaceuticals - Neuropsychiatry (CNS) | - | - | 21TCr | 24TCr | 26TCr | |||||
Gross Profit | - | - | 20TCr | 24TCr | 26TCr | |||||
Operating Income | - | - | 17TCr | 21TCr | 23TCr | |||||
Pharmaceuticals - General Medicines (GM) | - | - | 23TCr | 25TCr | 25TCr | |||||
Gross Profit | - | - | 12TCr | 13TCr | 13TCr | |||||
Operating Income | - | - | 4.33TCr | 4TCr | 3.7TCr | |||||
Pharmaceuticals - Pharma Other | - | - | 1.3TCr | 1.11TCr | 699.4Cr | |||||
Gross Profit | - | - | 173.1Cr | 29Cr | -171.2Cr | |||||
Operating Income | - | - | -62Cr | -167.5Cr | -317.5Cr | |||||
Pharmaceuticals | 51TCr | 66TCr | - | - | - | |||||
Total Assets | 1,22000Cr | 1,41200Cr | - | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
CAPEX | -14TCr | -7.12TCr | - | - | - | |||||
Gross Profit | 34TCr | 45TCr | - | - | - | |||||
D&A | 4.34TCr | 4.7TCr | - | - | - | |||||
Operating Income | 14TCr | 15TCr | - | - | - | |||||
Biological Products | ||||||||||
Pharmaceuticals - Biotechnology (BIO) | - | - | 4.62TCr | 5.4TCr | 6.42TCr | |||||
Gross Profit | - | - | 1.68TCr | 2.07TCr | 2.57TCr | |||||
Operating Income | - | - | -2.07TCr | -1.78TCr | -1.33TCr | |||||
Pharmaceutical Product Distribution | ||||||||||
Other | 715Cr | 971.7Cr | 7.09TCr | 2.5TCr | 2.56TCr | |||||
Total Assets | 410.4Cr | 2.27TCr | - | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
CAPEX | -26Cr | -31Cr | - | - | - | |||||
Gross Profit | 80Cr | 63Cr | 765.1Cr | 543.2Cr | 521.8Cr | |||||
D&A | 20Cr | 22Cr | - | - | - | |||||
Operating Income | 39Cr | 14Cr | -68Cr | 103Cr | 65Cr | |||||
Wholesale and Retail | 13TCr | 15TCr | - | - | - | |||||
Total Assets | 7.14TCr | 8.59TCr | - | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
CAPEX | -60Cr | -10Cr | - | - | - | |||||
Gross Profit | 1.02TCr | 1.24TCr | - | - | - | |||||
D&A | 128.8Cr | 137.3Cr | - | - | - | |||||
Operating Income | 46Cr | -4.9Cr | - | - | - | |||||
Eliminations | -1.58TCr | -1.79TCr | -1.32TCr | -1.22TCr | -1.06TCr | |||||
Total Assets | -15TCr | -18TCr | - | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
CAPEX | 2Cr | - | - | - | - | |||||
Gross Profit | -4.7Cr | 1.9Cr | -32Cr | -52Cr | 83Cr | |||||
D&A | - | - | - | - | - | |||||
Operating Income | -6.6Cr | 137.5Cr | -32Cr | -52Cr | 83Cr |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Europe | 26TCr | 33TCr | 50TCr | 51TCr | 55TCr | |||||
Total Assets | 16TCr | 20TCr | 1,32000Cr | 1,55700Cr | 1,65600Cr | |||||
CAPEX | -1.15TCr | -1.84TCr | -9.41TCr | -6.31TCr | -6.54TCr | |||||
North America | - | - | 22TCr | 26TCr | 28TCr | |||||
Total Assets | - | - | 309.2Cr | 95Cr | 98Cr | |||||
CAPEX | - | - | - | -10L | - | |||||
APAC | - | - | 4.31TCr | 4.86TCr | 5.47TCr | |||||
Total Assets | - | - | 1.46TCr | 1.87TCr | 1.57TCr | |||||
CAPEX | - | - | -34Cr | -44Cr | -89Cr | |||||
Latin America | 1.76TCr | 2.79TCr | 3.17TCr | 3.55TCr | 3.83TCr | |||||
Total Assets | 1.02TCr | 2.02TCr | 2.31TCr | 2.62TCr | 2.5TCr | |||||
CAPEX | -24Cr | -28Cr | -22Cr | -22Cr | -8.2Cr | |||||
Rest of The World | 3.12TCr | 3.65TCr | 826.2Cr | 670.6Cr | 904.9Cr | |||||
Total Assets | 1.46TCr | 1.56TCr | - | - | - | |||||
CAPEX | -46Cr | -30Cr | - | - | - | |||||
EU 12 (Excluding Poland and Romania) | - | - | - | - | - | |||||
China | 1.56TCr | 2.17TCr | - | - | - | |||||
Total Assets | 198.7Cr | 505.7Cr | - | - | - | |||||
Other CIS Republics | - | - | - | - | - | |||||
Ukraine | - | - | - | - | - | |||||
Russia | - | - | - | - | - | |||||
WEU | - | - | - | - | - | |||||
Poland | - | - | - | - | - | |||||
Romania | - | - | - | - | - | |||||
Hungary | 4.44TCr | 4.66TCr | - | - | - | |||||
Total Assets | 89TCr | 1LCr | - | - | - | |||||
CAPEX | -13TCr | -5.21TCr | - | - | - | |||||
CIS (Commonwealth of Independent States) | 14TCr | 18TCr | - | - | - | |||||
Total Assets | 7.05TCr | 10TCr | - | - | - | |||||
CAPEX | -396.2Cr | -55Cr | - | - | - | |||||
United States of America | 12TCr | 16TCr | - | - | - | |||||
Total Assets | 415.2Cr | 286.2Cr | - | - | - | |||||
CAPEX | - | - | - | - | - |
- Stock Market
- Stocks
- RICHTER Stock
- RIG2 Stock
- Financials Gedeon Richter
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
















